RegeneRx Receives Notice of Allowance for Key U.S. Heart Patent - Regenerx (OTC:RGRX)

27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.

RegeneRx Biopharmaceuticals, Inc. (OTC: RGRX) today announced that it has received a notice of allowance from the U.S. Patent and Trademark Office for its application claiming methods for treating, preventing, inhibiting or reducing tissue deterioration due to congestive heart failure disease using Thymosin beta 4, its isoforms and fragments, and important analogs. The patent is projected to expire July 2027.

27% profits every 20 days?

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!